The CD30 Ligand Receptor, also known as CD30/TNFRSF8, is a member of the tumor necrosis factor receptor (TNFR) superfamily. It plays a crucial role in the regulation of immune responses and is involved in various cellular processes, including cell proliferation, differentiation, and apoptosis. The recombinant form of this receptor, tagged with IgG-His, is widely used in research to study its functions and interactions.
The CD30 receptor is a type I transmembrane glycoprotein expressed on the surface of activated T cells, B cells, and certain types of lymphoma cells. The recombinant version of this receptor is typically produced in human embryonic kidney (HEK293) cells, ensuring proper folding and post-translational modifications . The IgG-His tag facilitates purification and detection of the protein in various experimental setups.
CD30 interacts with its ligand, CD30L (also known as CD153 or TNFSF8), to mediate a range of biological effects. This interaction is critical in the context of immune responses, particularly in T cell-dependent immune reactions. CD30 signaling can lead to either cell proliferation or apoptosis, depending on the cellular context and the presence of other signaling molecules .
The recombinant CD30 Ligand Receptor, tagged with IgG-His, is a valuable tool in immunological research. It is used to study the signaling pathways activated by CD30-CD30L interactions and to investigate the role of CD30 in various diseases, including Hodgkin lymphoma and other hematologic malignancies . The His tag allows for easy purification and detection, making it suitable for use in various assays, including ELISA and Western blotting .